|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02912520 |
|
Date of registration:
|
13/09/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy
|
|
Scientific title:
|
Comparison of IgA Levels in the Bronchoalveolar Lavage Fluid of Patients With and Without Antibiotic Therapy |
|
Date of first enrolment:
|
June 2016 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02912520 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Austria
| | | | | | | |
|
Contacts
|
|
Name:
|
Oliver Robak, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Medical University of Vienna |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- endotracheal intubation
- antibiotic therapy for 2 weeks OR no antibiotic therapy for at least 3 months
Exclusion Criteria:
- active infection
- pregnancy
- immunodeficiency
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Immunoglobulin A
|
|
Intervention(s)
|
|
Drug: Anti-Bacterial Agents
|
|
Primary Outcome(s)
|
|
IgA levels in the bronchoalveolar lavage fluid
[Time Frame: 2 weeks of ICU stay]
|
|
Secondary Outcome(s)
|
|
number of detected bacterial, viral, and fungal infections per patient
[Time Frame: through study completion, an average of 2 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|